Researchers launched a unique collaboration on Wednesday aimed at getting cancer drugs to the market more quickly in which three companies will cooperate with the U.S. government and non-profit groups to test five experimental breast cancer drugs.
The five-year, $26 million study called Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis, or I-SPY2, will aim to use DNA to match the best drug to each patient and to more quickly toss out approaches that do not work or are too toxic.
"They'll get the latest and greatest in terms of targeted drugs," Dr. Anna Barker, deputy director of the National Cancer Institute, said in an interview.
"I think it's the future. Government couldn't have done it on their own and these companies couldn't have done it on their own."
Unusually, the companies agreed to share information on using genes to predict how well a patient will respond as part of the Biomarkers Consortium, which includes the U.S. Food and Drug Administration and the National Institutes of Health.
"I-SPY 2 will provide a path to personalized medicine," said Dr. Laura Esserman, a breast cancer surgeon at the University of California San Francisco who will help lead the clinical trials. "We intend that every drug will graduate with a companion marker."
The trial will match patients to one of five experimental drugs:
-- ABT-888 or veliparib, being developed by Abbott Laboratories. The pill is a PARP inhibitor, which blocks a cell repair enzyme used by cancer cells.
-- AMG 655 or conatumumab, a targeted drug being developed by Amgen. It boosts a protein called APO/TRAIL that causes cancer cells to self-destruct.
-- Amgen's AMG 386, an angiogenesis inhibitor that stops tumors from growing blood vessels to nourish themselves.
-- CP-751,871 or figitumumab, being developed by Pfizer Inc to target the insulin growth factor receptor or IGFR.
-- Pfizer's HKI-272 or neratinib, another targeted therapy called a Pan ErbB inhibitor that targets several related receptors used by cancer cells.
The group is negotiating with other companies to add their experimental drugs to the mix.
"It'll speed up the whole process," Barker said.
The drug company lobby group PhRMA estimates it can take as long as 15 years and cost more than $1.3 billion dollars to take a new drug from laboratory to pharmacy.
Patients at 20 cancer centers will be tested right after they get tiny samples of tissue taken in biopsies. Before they ever get surgery, they will be treated with one of the drugs to see if this helps prevent tumor spread.
Up to 12 different cancer drugs will be tested. Unusually, the group has FDA approval to drop and add drugs throughout the course of the trial without having to stop it to write a whole new protocol.
The idea came to Olivia Koburongo, 26, after her grandmother fell ill, and was moved from hospital to hospital before being properly diagnosed with pneumonia.
In the far-reaching health scandal, breast implants were later found to contain substandard, industrial-grade silicone gel that was seven times cheaper than medical-grade silicone.
Device eliminates risk of deadly blood clots; need for blood thinners
A new initiative will help transform readiness of countries against virus breakouts like those seen in Guinea, Liberia and Sierra Leone
Protest in Nairobi sees hundreds take to streets to back doctors' pay demands
The Arctic Council's recently released Arctic Resilience Report has shown how the Arctic is to specific abrupt environmental changes resulting from climate change and human activity: essentially, "tipping points".
Irrawaddy dolphins can be found in rivers, lakes and seas across southern Asia, from the northwest Bay of Bengal, in India, to the south of Indonesia but are now being killed by rogue gangs
Singaporean Seah Chiang Nee, a former newspaper editor, died aged 76 in a local hospital on Saturday, his wife Patricia Wong said. He was hospitalised in July.
Renault reacted with a statement saying that its cars "are not equipped with cheating software affecting anti-pollution systems."
Worldwide tobacco use causes loss of $1 trillion and six million lives annually, says World Health Organization
China now owns five of the six largest solar module manufacturing firms in the world, according to the report.
Some 7.7 million new cases of dementia are reported every year, with Alzheimer's disease being the most common cause and contributing to 60–70% of cases.
Funding is critical to support the humanitarian needs of the poorest country in the Americas, said Mourad Wahba, the deputy special representative for the UN's stabilization mission in Haiti.
Conservationists estimate that more than 20,000 elephants were killed for their ivory last year, with similar tolls in previous years. The WWF campaign group says 415,000 of the animals remain.
Spanish police enforce severe restrictions on traffic in the capital as health fears grow over air pollution
The outbreak erupted in December last year in the slums of the capital Luanda, spreading to 16 of Angola's 18 provinces and into neighbouring Democratic Republic of Congo.